Cell Culture Technology– category –
-
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stemchymal® Stem Cell Therapy for Spinocerebellar Ataxia (SCA3 and SCA6)
BioSpace Japan Overview REPROCELL Inc. has submitted an application for manufacturing and marketing approval in Japan for its regenerative medicine product, Stemchymal®, aimed at inhibiting the progression of motor ataxia in patients wit... -
AI and Machine Learning Optimize Protein Design for Cost Efficiency in Large-Scale Production, Achieving 20-30% Energy Reduction
PatSnap Eureka Global Overview Optimizing protein design for maximizing cost efficiency in large-scale production is significantly advanced by computational algorithms, machine learning, molecular dynamics simulations, and artificial int... -
Samsung Biologics Revolutionizes Bioprocess Manufacturing Intelligence by Integrating Digital Twin and AI for Proactive Decision-Making
Samsung Biologics South Korea Overview Samsung Biologics is revolutionizing manufacturing intelligence by advancing a digital bioprocess framework integrating multivariate data analysis (MVDA), predictive modeling, and explainable AI. Th... -
Lonza’s OptiALTO™ Platform Leverages Raman Spectroscopy as PAT to Significantly Boost High-Cell-Density Culture Productivity
Lonza Switzerland Overview Lonza's OptiALTO™ platform is achieving significant increases in productivity for high-cell-density cultures by integrating Raman spectroscopy as a Process Analytical Technology (PAT). This innovative approach ... -
UniXell Biotechnology Secures US FDA IND Clearance for Off-the-Shelf Parkinson’s Cell Therapy UX-DA003, Accelerating Dual China-US Clinical Development
BioPharma APAC USA Overview UniXell Biotechnology announced that its allogeneic iPSC-derived therapy UX-DA003 for Parkinson's disease has received Investigational New Drug (IND) approval from the US FDA. This approval enables the company... -
Cellforce One Clinic Tokyo Establishes ‘Cell Processing Governance’ Under Japan’s Regenerative Medicine Law, Offers MSC Therapies for Chronic Pain and Osteoarthritis
Cellforce One Clinic Tokyo Japan Overview Cellforce One Clinic Tokyo, offering integrated regenerative, preventive medicine, and precision imaging, announced the establishment of its 'Cell Processing Governance' in 2026, fully compliant ... -
Syntax Bio & Applied StemCell Partner to Accelerate Allogeneic iPSC Therapies with Low-Immunogenicity Lines and Cellgorithm Platform
Manufacturing Chemist USA Overview Syntax Bio and Applied StemCell have formed a strategic partnership to accelerate programmable iPSC therapy development. This collaboration aims to address key challenges of immune recognition and manuf... -
Japan Leads Global Ophthalmic Regenerative Medicine with First iPSC Retinal Transplant and Cultured Corneas, Backed by Proactive Regulation
Ophthoagent Japan Overview Japan has cemented its global leadership in advanced ophthalmic regenerative medicine, achieving groundbreaking clinical successes such as the world's first iPSC-derived retinal transplant in 2014 and successfu... -
BioInsights Reports >95% T-Cell Recovery with Closed-Loop Centrifugation, Streamlining Cell Therapy Workflows
BioInsights Global Overview The development of flexible, closed, end-to-end cell therapy manufacturing process workflows is progressing, with the Gibco™ CTS™ Rotea™ Counterflow Centrifugation System demonstrating over 95% primary activat... -
Thermo Fisher Scientific Unveils DynaXS Single-Use Bioreactor and Global Manufacturing Expansion at BIO 2026, Boosting Cell & Gene Therapy Production
Business Wire USA Overview Thermo Fisher Scientific announced significant new manufacturing capabilities and AI-enabled research advancements at BIO International 2026, aiming to strengthen the cell and gene therapy sector. Key highlight...
